Abstract
Purpose:
The purpose of this study was to evaluate the relationship between peripheral defocus and pupil size on axial growth in children randomly assigned to wear either single vision contact lenses, +1.50 diopter (D), or +2.50 D addition multifocal contact lenses (MFCLs).
Methods:
Children 7 to 11 years old with myopia (−0.75 to −5.00 D; spherical component) and ≤1.00 D astigmatism were enrolled. Autorefraction (horizontal meridian; right eye) was measured annually wearing contact lenses centrally and ±20 degrees, ±30 degrees, and ±40 degrees from the line of sight at near and distance. Photopic and mesopic pupil size were measured. The effects of peripheral defocus, treatment group, and pupil size on the 3-year change in axial length were modeled using multiple variables that evaluated defocus across the retina.
Results:
Although several peripheral defocus variables were associated with slower axial growth with MFCLs, they were either no longer significant or not meaningfully associated with eye growth after the treatment group was included in the model. The treatment group assignment better explained the slower eye growth with +2.50 MFCLs than peripheral defocus. Photopic and mesopic pupil size did not modify eye growth with the +2.50 MFCL (all P ≥ 0.37).
Conclusions:
The optical signal causing slower axial elongation with +2.50 MFCLs is better explained by the lens type worn than by peripheral defocus. The signal might be something other than peripheral defocus, or there is not a linear dose-response relationship within treatment groups. We found no evidence to support pupil size as a criterion when deciding which myopic children to treat with MFCLs.
The global prevalence of myopia is increasing.
1 The risk of comorbidities (such as myopic macular degeneration, retinal detachment, glaucoma, etc.) due to excessive axial elongation increases as myopia progresses, as does the economic impact and burden of healthcare associated with increases in myopia prevalence and severity.
1–5 There is evidence across animal species that eye development is visually guided, with the eyes of young animals increasing or decreasing the rate of axial elongation to match the sign and amount of lens-induced defocus.
6–8 Visually guided mechanisms regulating eye growth operate in a regionally specific manner in animal models with only the portion of the eye experiencing a visual signal changing growth in response.
9,10 However, it is not clear that this is the case in children based on our longitudinal myopia control peripheral eye growth data that found symmetric eye elongation across the periphery rather than enhanced peripheral inhibition in those wearing multifocal contact lenses in the Bifocal Lenses in Nearsighted Kids (BLINK) Study.
11 Animal experiments involving lenses with a clear central aperture that only produce peripheral hyperopia and normal central vision still result in accelerated axial eye growth, demonstrating that the peripheral retina can guide refractive error development.
12 Bi-directional changes in choroidal thickness have also been reported in response to the sign of defocus, providing further evidence that the eye detects the type of retinal blur.
13–15
Based on these results in animal models, optical treatment strategies that impose myopic retinal defocus have been investigated in children as a method to slow the progression of juvenile-onset myopia.
16 Although clinical trials evaluating progressive addition spectacle lenses found statistically significant but clinically small reductions in myopia progression,
17,18 this type of lens primarily causes myopic defocus in the superior retina as opposed to throughout the periphery.
19 Whereas spherical soft contact lenses can cause changes in peripheral defocus,
20,21 more significant changes are caused by orthokeratology
22 and rotationally symmetric center-distance soft multifocal contact lenses,
23–25 which create myopic defocus throughout the retinal periphery while maintaining good visual acuity.
Randomized clinical trials ranging from 2 to 3 years in duration evaluating orthokeratology
26,27 and soft multifocal contact lenses
28,29 have had success in slowing myopia progression and eye growth compared to single vision corrections. Spectacle designs that incorporate plus power throughout the lens outside of a central clear zone have also had success in slowing myopia progression.
30,31 These optical treatments are hypothesized to slow eye growth by imposing myopic defocus on the retina; however, testing of this hypothesis is needed. Larger pupil size is also hypothesized to enhance the myopia control effect by exposing more of the retina to the plus power in these optical treatments, thereby enhancing the myopia control effect.
32–34
The BLINK Study found children wearing +2.50 add center-distance multifocal contact lenses had less axial growth over 3 years compared to children wearing single vision contact lenses, but children wearing +1.50 add multifocal contact lenses did not have slower progression.
29 The purpose of this analysis was to determine whether peripheral defocus created by multifocal contact lenses was associated with the 3-year reduction in axial elongation. We also investigated whether pupil size modified the slowing of axial elongation with multifocal contact lenses.
Of the aggregate metrics of defocus that equally weighted peripheral defocus across the retina, mean peripheral defocus at distance performed the best at explaining a portion of the −0.23 mm 3-year slowing of axial growth in children wearing +2.50 multifocal contact lenses in the BLINK Study. That said, even without the treatment group in the model, this variable only explained 30% of the treatment effect. Once the treatment group was added to the model, the strongest aggregate metrics (mean peripheral defocus at distance and mean most myopic meridian at distance) were no longer significant, indicating the lens type worn better explained the slower eye growth than averaged peripheral defocus or the most myopic astigmatic signal. Although lenses that only change peripheral defocus in animal models alter axial growth even with unrestricted central vision,
12 our results do not support equally weighted peripheral defocus being the signal responsible for this altered growth.
We also evaluated distance retinal defocus by location prior to including treatment group in the models. Defocus 30 degrees temporal on the retina explained 48% of the reduction in axial growth with the +2.50 multifocal, followed by 20 degrees temporal (43%), 40 degrees nasal (26%), and 40 degrees temporal (17%). Defocus 20 degrees and 30 degrees temporal on the retina were the two locations where, on average, the +2.50 multifocal caused the largest myopic shifts compared to single vision lenses and caused the largest amounts of myopic retinal defocus. Although the largest myopic shift was found at 40 degrees nasal, the average defocus at this location was still hyperopic (+0.23 D), which could suggest the poorer association at that location was because myopic defocus was often not achieved. Unexpectedly, the opposite association was found at 20 degrees nasal (myopic defocus was associated with faster growth), although this finding could be due to proximity to the optic nerve where eye growth characteristics and defocus influence may be different due to anatomic differences.
Most associations between location-specific defocus and the change in axial length were no longer significant after adding treatment group to the model. Only 30 degrees temporal defocus remained significant, explaining 25% of the treatment effect versus 48% before adding treatment group. The 30 degrees temporal location did have one of the highest myopic changes in defocus with multifocal contact lenses; however, other locations either lost significance after adding treatment group to the model or had the sign of the association flip (hyperopic defocus now associated with slower axial growth). These defocus signals losing significance or having a minimized and mixed association with axial growth suggests that defocus accounts for very little of the variability in axial elongation within treatment groups. Further research is needed to explore alternate optical hypotheses to account for the slower axial growth observed with the +2.50 additional multifocal contact lens.
Higher accommodative lag during near work has been hypothesized to influence myopia onset and progression.
41,42 Central defocus at near was not associated with the 3-year change in axial length. Although the +2.50 multifocal group had less eye growth on average, near central defocus was +0.21 D more hyperopic on average than the single vision group despite having less peripheral hyperopic defocus. Failing to find an association between central defocus at near and the 3-year change in axial length is consistent with other longitudinal studies of children.
17,43,44
We previously reported that +2.50 multifocal lenses symmetrically reduced peripheral eye growth in the BLINK Study.
11 This symmetrical growth was despite myopic defocus in the periphery when wearing +2.50 multifocal contact lenses. One might interpret the associations we found between local myopic defocus in the periphery and slower axial growth (before treatment group was added to the model) as evidence for local control. However, our previous finding that inhibition of growth was greater at the fovea than in the periphery for multifocal lens wearers does not support the local control reported in young animal models.
9,10 Our results suggest that the optical mechanism behind slowed axial growth with multifocal contact lenses is either due to spatial integration across the retina or some other mechanism than defocus.
Few longitudinal clinical trials have concurrently measured peripheral defocus with an optical correction to test whether defocus can explain observed treatment effects. The Study of Theories about Myopia Progression (STAMP) measured peripheral defocus in myopic children wearing single vision or progressive addition spectacles and found an association between myopic defocus on the superior retina caused by the progressive addition spectacle add and slower myopia progression, but the overall slowing after 1 year, although statistically significant, was clinically small (0.18 D less myopia progression).
17,19 Sankaridurg et al. evaluated relative peripheral hyperopia (the difference between peripheral and central defocus) in myopic children wearing a novel contact lens design compared to a matched control group wearing single vision spectacles and found a statistically significant association between more relative peripheral hyperopia and faster myopia progression over a 1-year period; however, the associations were small explaining very little of the variability of myopia progression over 1 year.
45 Studies have also evaluated whether dioptric changes in corneal curvature due to mid-peripheral steepening caused by orthokeratology (a surrogate for changes in peripheral defocus) are associated with changes in axial growth and have reported mixed results; one study found an association whereas another did not.
46,47 When our results are considered in context with these other studies, findings of an association between peripheral defocus and axial growth in myopic children are inconsistent and often weak when an association is present.
Our lack of a robust association between peripheral defocus and axial growth suggests that optical attributes other than defocus could be responsible for the myopia control effect. A limitation of the Grand Seiko autorefractor used to measure defocus is that it averages over a 2.3 mm diameter
48 and does not measure higher-order aberrations. Defocus values do not capture the complex effects of both lower-order and higher-order aberrations. Peripheral aberrometry is necessary to explore alternate theories of how multifocal lenses slow eye growth involving image quality, changes in retinal contrast, depth of focus, or anisotropy.
49 Based on the analysis of a number of myopia control studies, it has also been proposed that there may be a maximum cumulative treatment effect possible over time regardless of the rate of myopia progression.
50 If the size of the treatment effect is constant regardless of the underlying hypothesized progression rate or if there is some individual threshold level of defocus necessary to slow eye growth, we would not expect a correlation between the amount of defocus and axial growth, which would create a challenge in isolating the optical factor related to the treatment effect whether that factor is defocus or some other optical signal.
Another limitation is that due to the time involved in measuring peripheral refraction in children and contact lens decentration challenges if the eye must be rotated, peripheral measurements while wearing contact lenses were limited to the horizontal meridian and two viewing locations (distance and a 3 diopter near demand). The selected measurement conditions do not fully capture the complex dioptric visual scenes to which the eye is exposed on a daily basis.
2 Mountable devices that can objectively capture information regarding viewing distance and the visual environment could be beneficial in future studies.
Due to the time required to measure peripheral refraction with the Grand Seiko autorefractor and study examination flow considerations, we measured near defocus with the habitual lens power and distance defocus with the updated contact lens power being dispensed at that visit. Because updating the contact lens power immediately before measuring near defocus would not have allowed time to adapt to the new power and could have had a temporary effect on accommodation, we chose to measure near defocus with the habitual lens worn to the visit (representing what the child had most recently experienced at near). Because distance defocus was measured after cycloplegia, we updated the contact lens power to what was being dispensed to optimize vision (capturing the maximum amount of defocus caused by the lens with the updated prescription). In reality, the eye experiences a continuum of defocus between optimal correction and what is experienced 6 months later after any myopia progression.
We also did not find evidence that pupil size modified the magnitude of the treatment effect when children wore multifocal lenses in the BLINK Study, again suggesting that a mechanism other than peripheral defocus may be involved. Larger pupils have been hypothesized to result in a greater treatment effect by exposing more of the retina to plus power. Although a study of children fitted with orthokeratology reported that larger pupils resulted in a greater slowing of axial growth versus matched controls wearing single vision spectacles, the children with smaller pupils in their orthokeratology group also had 0.27 mm faster eye growth than children with smaller pupils wearing single vision spectacles, suggesting the pupil size effect may be confounded.
33 Another orthokeratology study that evaluated pupil size and eye growth over 2 years also reported that larger pupils were associated with slower eye growth in univariate models, although the effect of pupil size was no longer significant in a multivariate model that controlled for other factors associated with eye growth.
34 A study evaluating the combined effect of orthokeratology and low-dose (0.01%) atropine reported larger pupils and a better treatment effect with this combination therapy versus orthokeratology alone, but it is unclear whether the enhanced effect is due to a larger pupil with atropine or a synergistic effect via a pharmacological mechanism.
51 A study evaluating the +2.50 multifocal used in the BLINK Study in combination with 0.01% atropine and matched controls from the BLINK Study did not find additional significant slowing of axial growth with adding low-dose atropine despite an increase in pupil size.
52
Executive Committee: Jeffrey J. Walline, OD, PhD, FAAO (Study Chair); David A. Berntsen, OD, PhD, FAAO (UH Clinic Principal Investigator); Donald O. Mutti, OD, PhD, FAAO (OSU Clinic Principal Investigator); Lisa A. Jordan, PhD, FAAO (Data Coordinating Center Director); Donald F. Everett, MAS (NEI Program Official, 2014–2019); and Jimmy Le, ScD (NEI Program Official, 2019-present).
Chair's Center: The Ohio State University College of Optometry; Columbus, OH.
Kimberly J. Shaw, CCRP (Study Coordinator); Jenny Huang Jones, OD, PhD, FAAO (Investigator, 2014–2019); and Bradley E. Dougherty, OD, PhD, FAAO (Consultant, 2020-present).
Data Coordinating Center: The Ohio State University College of Optometry; Columbus, OH.
Loraine T. Sinnott, PhD (Biostatistician); Matthew L. Robich, MPH (Biostatistician, 2020-present); and Pamela W. Wessel (Program Coordinator, 2014–2017, deceased).
University of Houston Clinic Site: University of Houston College of Optometry; Houston, TX.
Laura Cardenas (Clinic Coordinator); Krystal L. Schulle, OD, FAAO (Examiner, 2014–2019); Dashaini V. Retnasothie, OD, MS, FAAO (Examiner, 2014–2015); Amber Gaume Giannoni, OD, FAAO (Examiner); Anita Tićak, OD, MS, FAAO (Examiner); Maria K. Walker, OD, PhD, FAAO (Examiner); Moriah A. Chandler, OD, FAAO (Examiner, 2016-present); Mylan T. Nguyen, OD, MS, MSPH, FAAO (Data Entry, 2016–2017); Lea A. Hair, OD, MS (Data Entry, 2017–2019); Augustine N. Nti, OD, PhD, FAAO (Data Entry, 2019–2022); Justina R. Assaad, OD, FAAO (Examiner, 2022-present); and Erin S. Tomiyama, OD, PhD, FAAO (Examiner, 2019–2022).
Ohio State University Clinic Site: (The Ohio State University College of Optometry).
Jill A. Myers (Clinic Coordinator); Alex D. Nixon, OD, MS, FAAO (Examiner, 2014–2019); Katherine M. Bickle, OD, PhD, FAAO (Examiner, 2014–2020); Gilbert E. Pierce, OD, PhD, FAAO (Examiner, 2014–2019, deceased); Kathleen S. Reuter, OD (Examiner, 2014–2019); Dustin J. Gardner, OD, MS, FAAO (Examiner, 2014–2016); Matthew Kowalski (Examiner, 2016–2017); Ann Morrison, OD, PhD, FAAO (Examiner, 2017–2019); Danielle J. Orr, OD, MS, FAAO (Examiner, 2018-present); Elizabeth Day, OD, MS (Examiner, 2019-present); and Rachel Fenton, OD, MS (Examiner, 2020-present).
Data Safety and Monitoring Committee: Janet T. Holbrook (Chair, Johns Hopkins Bloomberg School of Public Health), Jane Gwiazda (Member, New England College of Optometry), John Mark Jackson (Member, Southern College of Optometry), and Charlotte E. Joslin (Member, University of Illinois at Chicago)
Supported by National Institutes of Health (NIH) U10-EY023204, U10-EY023206, U10-EY023208, U10-EY023210, P30-EY007551, and UL1-TR002733. Bausch + Lomb (contact lens solution).
Disclosure: D.A. Berntsen, Bausch + Lomb (F); A. Ticak, Bausch + Lomb (F); L.T. Sinnott, Bausch + Lomb (F); M.A. Chandler, Bausch + Lomb (F); J.H. Jones, Bausch + Lomb (F), Alcon Research LLC (E); A. Morrison, Bausch + Lomb (F); L.A. Jones-Jordan, Bausch + Lomb (F); J.J. Walline, Bausch + Lomb (F), Myoptechs Inc. (C); D.O. Mutti, Bausch + Lomb (F), Vyluma (C)